Xponance’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.14M | Buy |
7,442
+25
| +0.3% | +$7.18K | 0.02% | 521 |
|
|
2025
Q1 | $2.29M | Buy |
7,417
+67
| +0.9% | +$20.7K | 0.02% | 493 |
|
|
2024
Q4 | $2.59M | Buy |
7,350
+605
| +9% | +$213K | 0.02% | 462 |
|
|
2024
Q3 | $2.42M | Sell |
6,745
-134
| -2% | -$48K | 0.02% | 469 |
|
|
2024
Q2 | $2.19M | Sell |
6,879
-838
| -11% | -$267K | 0.02% | 474 |
|
|
2024
Q1 | $1.77M | Buy |
7,717
+2,116
| +38% | +$486K | 0.02% | 550 |
|
|
2023
Q4 | $1.23M | Buy |
5,601
+7
| +0.1% | +$1.54K | 0.01% | 602 |
|
|
2023
Q3 | $1.26M | Sell |
5,594
-105
| -2% | -$23.7K | 0.02% | 583 |
|
|
2023
Q2 | $1.26M | Sell |
5,699
-407
| -7% | -$89.8K | 0.02% | 588 |
|
|
2023
Q1 | $1.37M | Buy |
6,106
+73
| +1% | +$16.3K | 0.02% | 556 |
|
|
2022
Q4 | $1.68M | Buy |
6,033
+622
| +11% | +$173K | 0.03% | 491 |
|
|
2022
Q3 | $1.13M | Sell |
5,411
-27
| -0.5% | -$5.65K | 0.02% | 536 |
|
|
2022
Q2 | $1.28M | Buy |
5,438
+399
| +8% | +$94K | 0.03% | 506 |
|
|
2022
Q1 | $904K | Sell |
5,039
-18
| -0.4% | -$3.23K | 0.02% | 629 |
|
|
2021
Q4 | $1.09M | Sell |
5,057
-58
| -1% | -$12.5K | 0.02% | 573 |
|
|
2021
Q3 | $944K | Sell |
5,115
-174
| -3% | -$32.1K | 0.02% | 589 |
|
|
2021
Q2 | $949K | Buy |
5,289
+559
| +12% | +$100K | 0.02% | 620 |
|
|
2021
Q1 | $791K | Buy |
4,730
+4
| +0.1% | +$669 | 0.02% | 566 |
|
|
2020
Q4 | $717K | Buy |
4,726
+1
| +0% | +$152 | 0.02% | 592 |
|
|
2020
Q3 | $477K | Buy |
4,725
+696
| +17% | +$70.3K | 0.01% | 663 |
|
|
2020
Q2 | $488K | Buy |
+4,029
| New | +$488K | 0.01% | 619 |
|